NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
NeoGenomics Reports Second Quarter 2026 Results
For more information regarding accessibility, please use the following form to contact us
* denotes a required field